Skip to main content

Posts

Showing posts with the label TATA Motors

Stock Market News- Yes Bank, TATA Motors Top Losers, ICRA tanks 4%

Yes Bank, TATA Motors Top Losers - Shares of Yes Bank, Tata Motors were among the biggest losers, shedding up to 1.51%.  Global stocks rallied and bonds retreated on Monday as the United States and China agreed to restart trade talks at the G20 summit over the weekend, leading investors to bet that a breakthrough between the world’s two largest economies would jumpstart global economic growth, Reuters reported. Sadbhav Infra Resumes Rally After A One-Day Blip -  Shares of Sadbhav Infrastructure Project rose as much as 9.9 percent to Rs 78. The stock has gained during Three trading sessions out of four. The company’s board approved the sale of entire stake in nine SPV comprising of seven toll road infra assets and two annuity infra assets to lndlnfravit Trust at a deal valued at Rs 6,611.2 crore, according to its stock exchange filing. Sadbhav infra will see a de-consolidation of net debt of Rs 4,060 crore. Hero Motocorp June sales: Total sales in June 2019 dec...

Stock Market News - Tata Motor, Maruti slip 2%: Aurobindo Falls

Tata Motors Worst Performer On Sensex-   Nifty Shares of Tata Motors fell as much as 3 percent to Rs 154.50, making them the worst performer on Sensex and Nifty. Moody's Investor Services Inc. downgraded the company’s corporate family rating and senior unsecured instruments rating, citing sustained deterioration in the company's credit profile due to Jaguar Land Rover Plc 's weak performance. Maruti Suzuki Declines -  After UBS Downgrades Stock Rating, Cut Price Target Shares of the country’s largest carmaker fell as much as 3.3 percent to Rs 6,400. Brokerage and research firm UBS downgraded the stock rating to ‘Sell’ from ‘Buy’ and cut-price target to Rs 5,800 from Rs 8,000, according to their research report. NEWS ALERT |  Aurobindo Pharma gets a warning letter from US FDA after Feb inspection:    Unit XI gets a warning letter Aurobindo Pharma Near 11-Month Low As Regulatory Concerns Prevail Shares of Aurobindo Pharma fell as much as 7....